| Literature DB >> 26241220 |
Zaher S Azzam1, Jacob I Sznajder2.
Abstract
Pulmonary edema clearance is necessary for patients with lung injury to recover and survive. The mechanisms regulating edema clearance from the lungs are distinct from the factors contributing edema formation during injury. Edema clearance is effected via vectorial transport of Na(+) out of the airspaces which generates an osmotic gradient causing water to follow the gradient out of the cells. This Na(+) transport across the alveolar epithelium is mostly effected via apical Na(+) and chloride channels and basolateral Na,K-ATPase. The Na,K-ATPase pumps Na(+) out of the cell and K(+) into the cell against their respective gradients in an ATP-consuming reaction. Two mechanisms contribute to the regulation of the Na,K-ATPase activity:recruitment of its subunits from intracellular compartments into the basolateral membrane, and transcriptional/translational regulation. Na,K-ATPase activity and edema clearance are increased by catecholamines, aldosterone, vasopressin, overexpression of the pump genes, and others. During lung injury, mechanisms regulating edema clearance are inhibited by yet unclear pathways. Better understanding of the mechanisms that regulate pulmonary edema clearance may lead to therapeutic interventions that counterbalance the inhibition of edema clearance during lung injury and improve the lungs' ability to clear fluid, which is crucial for patient survival.Entities:
Year: 2015 PMID: 26241220 PMCID: PMC4524398 DOI: 10.5041/RMMJ.10210
Source DB: PubMed Journal: Rambam Maimonides Med J ISSN: 2076-9172
Figure 1Schematic Representation of Alveolar Epithelial Cells with the Components that Contribute to the Alveolar Fluid Clearance Process
AECI, alveolar epithelial cell type I; AECII, alveolar epithelial cell type II; ENaC, epithelial Na+ channel; Na,K-ATPase, sodium-potassium pump.
Figure 2The Effect of Various Pharmacologic and Pathophysiologic Conditions on Alveolar Fluid Clearance
A: The rate of alveolar fluid clearance (AFC) was modulated following therapeutic interventions: catecholamines, vasopressin, and gene therapy upregulated AFC; however, the administration of endothelin, angiotensin, amiloride, ouabain, or colchicine inhibited active sodium transport and thus AFC. The data were adapted from references 13, 27, 28, 31, 33, 36, 37.
B: Alveolar fluid clearance (AFC) was decreased in the various states of acute lung injury, such as sepsis, hyperoxia, hypercapnia, and ventilation-induced lung injury. Moreover, in rats exposed to acutely increased left atrial pressure (e.g. acute left heart failure) AFC was inhibited; whereas AFC was significantly upregulated in chronic heart failure rats. The data were adapted from references 34, 40–43.
The bars represent mean ± SEM. Alfa2, α2-subunit of Na,K-ATPase; Ami, amiloride; beta1, β1-subunit of Na,K-ATPase; beta2 adr, β2 adrenergic receptor; CT, control; Ouab, ouabain; VILI, ventilation-induced lung injury.
Figure 3Schematic Representation of Active Sodium Transport in the Alveolar Epithelial Cell Depicting Apical Na+ Channels, Basolaterally Located Na,K-ATPase, Aquaporins, and Co-transporters
Sodium enters through the apical membrane via Na+ channels and is extruded by the Na,K-ATPase, with water following iso-osmotically. Proposed mechanisms by which norepinephrine upregulates active sodium transport and alveolar clearance.